logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Lymphedema

    FiltersReset Filters
    9 results

    • edecrin

      (ethacrynic acid)
      Bausch Health US, LLC
      Usage: EDECRIN is indicated for treating edema related to congestive heart failure, cirrhosis, renal disease, and nephrotic syndrome. It also manages ascites, idiopathic edema, and lymphedema, particularly in hospitalized pediatric patients. Intravenous use is designated for rapid diuresis in acute situations or when oral administration is not an option.

    • ethacrynate sodium

      (ETHACRYNATE SODIUM)
      Leading Pharma, LLC
      Usage: Ethacrynic acid is indicated for treating edema in conditions such as congestive heart failure, liver cirrhosis, and renal disease. It is also used for short-term management of malignancy-related ascites, idiopathic edema, and pediatric patients with specific heart conditions, particularly when rapid diuresis is needed.

    • ethacrynate sodium

      (ethacrynate sodium)
      Par Pharmaceutical, Inc.
      Usage: Ethacrynate sodium is indicated for treating edema associated with congestive heart failure, liver cirrhosis, renal disease, malignancy-related ascites, idiopathic edema, lymphedema, and hospitalized pediatric patients with congenital heart disease. It is also used intravenously for rapid diuresis in acute conditions or when oral administration is impractical.

    • ethacrynic acid

      (Ethacrynic acid)
      TRUPHARMA LLC
      Usage: Ethacrynic Acid Tablets are indicated for treating edema requiring potent diuresis, associated with conditions like congestive heart failure, liver cirrhosis, and renal disease. They are also used for managing ascites, idiopathic edema, and lymphedema, and for hospitalized pediatric patients with specific conditions. Intravenous forms are for rapid diuresis.

    • ethacrynic acid

      (Ethacrynic Acid)
      ScieGen Pharmaceuticals Inc
      Usage: Ethacrynic Acid Tablets are indicated for treating edema when stronger diuretics are needed, including conditions like congestive heart failure, liver cirrhosis, renal disease, and short-term management of ascites, idiopathic edema, lymphedema, and in pediatric patients with congenital heart disease or nephrotic syndrome.

    • ethacrynic acid

      (Ethacrynic Acid)
      Amneal Pharmaceuticals NY LLC
      Usage: Ethacrynic acid tablets are indicated for edema treatment requiring stronger diuretics, including conditions like congestive heart failure, cirrhosis, renal disease, ascites, and more. Intravenous formulation is used for rapid diuresis or when oral administration is not feasible, such as in acute pulmonary edema.

    • isosulfan blue

      (Isosulfan Blue)
      Meitheal Pharmaceuticals Inc.
      Usage: Isosulfan Blue Injection 1% is used for lymphatic vessel delineation to assist in lymphography for conditions such as primary and secondary lymphedema, chyluria, chylous ascites, chylothorax, and lymph node involvement or response to cancer therapy.

    • isosulfan blue

      (Isosulfan Blue)
      Somerset Therapeutics, LLC
      Usage: Isosulfan blue injection 1% is indicated for lymphatic vessel delineation in various conditions, including primary and secondary lymphedema, chyluria, chylous ascites, chylothorax, and assessment of lymph node involvement by neoplasms. It serves as an adjunct to lymphography in these clinical scenarios.

    • isosulfan blue

      (Isosulfan Blue)
      Mylan Institutional LLC
      Usage: Isosulfan blue injection 1% is used for delineating lymphatic vessels. It serves as an adjunct in lymphography for conditions such as primary and secondary lymphedema, chyluria, chylous ascites, chylothorax, and assessing lymph node involvement in neoplasms or response to therapies.